Adaptimmune Therapeutics plc

What is Adaptimmune Therapeutics plc (ADAP) stock price today?

As of Nov 21, 2025, 2:30 PM UTC, Adaptimmune Therapeutics plc (ADAP) stock is trading at $0.0485. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date ADAP stock quotes for informed trading decisions.

What is Adaptimmune Therapeutics plc's market capitalization?

Adaptimmune Therapeutics plc (ADAP) has a market capitalization of approximately $75.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Adaptimmune Therapeutics plc's size relative to other companies in the USD market. The market cap figure updates automatically as the ADAP stock price changes.

What is the 52-week range for Adaptimmune Therapeutics plc stock?

Adaptimmune Therapeutics plc (ADAP) stock has traded in a 52-week range of $0.0202 — $0.86. The 52-week range shows the highest and lowest prices at which ADAP traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Adaptimmune Therapeutics plc stock price to this range provides context for recent price action.

How much trading volume does Adaptimmune Therapeutics plc stock have?

Adaptimmune Therapeutics plc (ADAP) stock recently traded approximately 1.7M shares. Trading volume indicates market liquidity and investor interest in ADAP. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Adaptimmune Therapeutics plc stock.

Does Adaptimmune Therapeutics plc pay dividends to shareholders?

Yes, Adaptimmune Therapeutics plc (ADAP) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Adaptimmune Therapeutics plc stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Adaptimmune Therapeutics plc's intraday price range?

Today, Adaptimmune Therapeutics plc (ADAP) stock has traded in a range of $0.0425 — $0.0599. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring ADAP's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Adaptimmune Therapeutics plc stock data?

AlphaPilot sources real-time ADAP stock quotes, fundamental financial data, and historical price charts for Adaptimmune Therapeutics plc from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Adaptimmune Therapeutics plc stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of ADAP stock performance.